DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name | UniProt ID ▼ |
---|---|---|---|---|---|
C1861172 | Venous Thromboembolism | A4GALT | 53947 | alpha 1,4-galactosyltransferase (P blood group) | Q9NPC4 |
C0006826 | Malignant Neoplasms | A4GALT | 53947 | alpha 1,4-galactosyltransferase (P blood group) | Q9NPC4 |
C0019061 | Hemolytic-Uremic Syndrome | A4GALT | 53947 | alpha 1,4-galactosyltransferase (P blood group) | Q9NPC4 |
C0023418 | leukemia | A4GALT | 53947 | alpha 1,4-galactosyltransferase (P blood group) | Q9NPC4 |
C0376544 | Hematopoietic Neoplasms | A4GALT | 53947 | alpha 1,4-galactosyltransferase (P blood group) | Q9NPC4 |
C0206664 | Teratocarcinoma | A4GALT | 53947 | alpha 1,4-galactosyltransferase (P blood group) | Q9NPC4 |
C0006413 | Burkitt Lymphoma | A4GALT | 53947 | alpha 1,4-galactosyltransferase (P blood group) | Q9NPC4 |
C0020497 | Cortical Congenital Hyperostosis | A4GALT | 53947 | alpha 1,4-galactosyltransferase (P blood group) | Q9NPC4 |
C0278701 | Gastric Adenocarcinoma | A4GALT | 53947 | alpha 1,4-galactosyltransferase (P blood group) | Q9NPC4 |
C0001418 | Adenocarcinoma | A4GALT | 53947 | alpha 1,4-galactosyltransferase (P blood group) | Q9NPC4 |
C0013473 | Eating Disorders | GPCPD1 | 56261 | glycerophosphocholine phosphodiesterase 1 | Q9NPB8 |
C0028754 | Obesity | GPCPD1 | 56261 | glycerophosphocholine phosphodiesterase 1 | Q9NPB8 |
C0476089 | Endometrial Carcinoma | GPCPD1 | 56261 | glycerophosphocholine phosphodiesterase 1 | Q9NPB8 |
C0795864 | Smith-Magenis syndrome | NT5M | 56953 | 5',3'-nucleotidase, mitochondrial | Q9NPB1 |
C0006826 | Malignant Neoplasms | MMP25 | 64386 | matrix metallopeptidase 25 | Q9NPA2 |
C0001342 | Acute periodontitis | MMP25 | 64386 | matrix metallopeptidase 25 | Q9NPA2 |
C0280324 | Laryngeal Squamous Cell Carcinoma | MMP25 | 64386 | matrix metallopeptidase 25 | Q9NPA2 |
C0002452 | Amelogenesis Imperfecta | MMP25 | 64386 | matrix metallopeptidase 25 | Q9NPA2 |
C0025286 | Meningioma | MMP25 | 64386 | matrix metallopeptidase 25 | Q9NPA2 |
C0027651 | Neoplasms | MMP25 | 64386 | matrix metallopeptidase 25 | Q9NPA2 |
C0007097 | Carcinoma | MMP25 | 64386 | matrix metallopeptidase 25 | Q9NPA2 |
C0029408 | Degenerative polyarthritis | MMP25 | 64386 | matrix metallopeptidase 25 | Q9NPA2 |
C0278595 | Adult Fibrosarcoma | MMP25 | 64386 | matrix metallopeptidase 25 | Q9NPA2 |
C0016057 | Fibrosarcoma | MMP25 | 64386 | matrix metallopeptidase 25 | Q9NPA2 |
C0009375 | Colonic Neoplasms | MMP25 | 64386 | matrix metallopeptidase 25 | Q9NPA2 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024